在性综合征中,莱瓦米索尔调节细胞的动蛋白细胞骨架
Susan T Veissi1, Tijmen van den Berge2,3, Joanna A E van Wijk4
1Department of Pediatric Nephrology, Amalia Children's Hospital, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.
莱瓦米索尔稳定了皮质细胞的活性细胞骨架,这对于治疗性综合征 (iNS) 至关重要. 这种类固醇节约药物通过葡萄糖皮质体受体起作用,为iNS患者提供了一种新的治疗途径.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 细胞生物学 细胞生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 细胞在球体疾病中至关重要,例如异常性性综合征 (iNS).
- 葡萄糖皮质类药物是主要的iNS疗法,但复发和毒性需要使用类固醇节约剂.
- 莱瓦米索尔在iNS中的分子机制,特别是它对受体细胞的非免疫作用,尚不清楚.
研究的目的:
- 在iNS.NS的背景下,研究勒瓦米索尔对人体 podocytes 的作用.
- 为了阐明通过levamisole对podocytes产生治疗作用的分子通路.
主要方法:
- 用levamisole治疗的人类 podocytes 的 RNA 测序.
- 使用纯氨基核糖 (PAN),脂聚糖 (LPS) 和iNS患者血来诱导 podocyte 损伤的功能测试.
- 涉及葡萄糖皮质体受体信号传递和Rho GTPase活性的机制研究.
主要成果:
- 莱瓦米索尔调节了参与细胞骨稳定和细胞重塑的基因.
- 莱瓦米索尔恢复了actin细胞骨架的完整性,细胞运动性和受损 podocytes 的粘附性.
- 莱瓦米索尔的有益作用通过葡萄糖皮质体受体信号传递和Rho GTPases的调节来介导.
结论:
- 莱瓦米索尔通过稳定actin细胞骨架对 podocytes 产生有益影响.
- 这些效应取决于葡萄糖皮质体受体信号传递.
- 莱瓦米索尔通过向细胞细胞骨完整性,代表了对iNS的有希望的治疗策略.
更多相关视频
11:36Cutaneous Leishmaniasis in the Dorsal Skin of Hamsters: a Useful Model for the Screening of Antileishmanial Drugs
Published on: April 21, 2012
07:38Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
相关概念视频
Actin Polymerization and Cell Motility
Actin cytoskeleton dynamics can produce pushing, pulling, and resistance forces that help the cell to migrate....
Role of Myosin in Cell Migration
Myosin II is a hexamer comprising two heavy chains with globular heads and coiled-coil tails, two regulatory light chains, and two essential light chains. The ATPase sites on the myosin heads hydrolyze ATP, and the released phosphate generates the force for contraction....
Mechanism of Lamellipodia Formation
Antihypertensive Drugs: Potassium-Sparing Diuretics
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Actin Filament Depolymerization
In F-actin, the ADF/cofilin proteins...
